Search results
India set to witness obesity pill revolution? As patents near expiry, pharma giants gear up for...
Financial Express· 8 hours agoBlockbuster obesity drugs like Ozempic and Wegovy have become a global sensation. Now the Indian...
Mangaluru: Carmel School celebrates Vanamohtsava
Daiji World· 1 day agoThe event, held in the school auditorium, was arranged by the enthusiastic students of Grade 2, along with the little ones from LKG and UKG. The festival...
Mumbai: St Peter's Association Mumbai celebrates the annual Saint festival
Daiji World· 1 day ago(Photo /News: Rons Bantwal) Mumbai, July 07: Mutual acquaintances foster close relationships. Such...
Mint Explainer: What the Labour Party's victory means for India-UK relations
Livemint· 3 days agoThe results, which poured in on Friday, indicated Labour Party leader Sir Keir Starmer was set to...
Roche gains FDA approval for Vabysmo prefilled syringe
Pharmaceutical Technology· 3 days agoRoche has received approval from the US Food and Drug Administration (FDA) for the Vabysmo...
Mint Primer | SCO Summit: What’s in it for New Delhi?
Livemint· 4 days agoIt evolved from an earlier avatar known as the Shanghai Five, comprising Russia, Kazakhstan,...
French and UK Stocks Outshine European Peers Ahead of Elections
Livemint· 4 days agoFrench stocks outperformed on Thursday, boosting the broader market, as polls showed Marine Le Pen’s National Rally and its allies would fall well short of an absolute majority in Sunday’s French ...
Next generation of biotechnologists can leverage the power of antibodies to drive significant...
The Times of India· 4 days agoIn the ever-evolving field of biotechnology, antibody engineering is a field brimming with...
Roche’s Phase II/III NSCLC treatment trial fails to meet primary endpoints
Clinical Trials Arena· 4 days agoRoche has reported that its Phase II/III SKYSCRAPER-06 clinical trial of tiragolumab along with...
European shares advance on rate optimism; UK elections in focus
The Economic Times· 4 days agoEuropean shares rose Thursday due to Fed rate cut prospects, weak U.S. data, and Labour gains. FTSE...